QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. MU
3. FDX
4. SPY
5. META
6. ABBV
7. NVDA
8. BLZE
9. IBM
10. NKE

Go back to QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2

Qiagen NV (QGEN) PT Raised to $58 at Cowen

November 4, 2021 5:42 PM EDT

Cowen analyst Dan Brennan raised the price target on Qiagen NV (NYSE: QGEN) to $58.00 (from $55.00) while maintaining a Market Perform rating.

The analyst commented, "COVID upside drove a 3Q beat while underlying base growth was shy of our forecast and... More